Codon Capital Invests in Biotech Teams Inventing a Better Future
The golden age of biotech is now
Codon Capital is a venture firm investing in visionary biotechnology entrepreneurs solving the most important problems in human and planetary health. These teams have the experience, talent, and persistence to overcome great challenges, and the right insight to match their technology to the most compelling unmet need.
Codon is the right partner
Karl and Mitchell have been working with extraordinary teams that have a track record of success as both investors and operators for over 20 years. Codon supports teams in advance of the Series A to discover the highest value product for their technology. We also help our teams establish a capital efficient development plan with the goal of demonstrating value within 18 months of the Series A financing.